J9308 HCPCS code: Injection, ramucirumab, 5 mg
J9308 is the HCPCS Level II code for injection, ramucirumab, 5 mg. In 2024 Medicare paid an average of $54.03 per service for J9308 across 704,943 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 280 per day on outpatient hospital claims. Medicare volume fell 8% from 2022 to 2024 (764,397 to 704,943 services). In 2024, about 1,352 clinicians billed Medicare for J9308 for 1,102 beneficiaries; Florida, California, Texas accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2016-01-01 |
| Last action effective | 2016-01-01 |
Who bills J9308 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,352 |
| Medicare beneficiaries | 1,102 |
| States with claims | 28 |
| Share of services in top 3 states (Florida, California, Texas) | 34% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9308, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 764,397 | 1,199 | $63.06 | $50.35 |
| 2023 | 802,825 | 1,226 | $65.60 | $52.27 |
| 2024 | 704,943 | 1,102 | $67.82 | $54.03 |
States with the most J9308 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 100,923 | $53.36 |
| California | 62,954 | $52.48 |
| Texas | 60,018 | $55.06 |
| Illinois | 47,995 | $55.16 |
| Tennessee | 42,380 | $55.31 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 280 | Clinical: Data |
| practitioner claims | 280 | Clinical: Data |
What changed for J9308
- 2016-01-01: J9308 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9308?
J9308 is the HCPCS Level II code for injection, ramucirumab, 5 mg. Short descriptor: "Injection, ramucirumab".
How much does Medicare pay for J9308?
In 2024, the average Medicare payment was $54.03 per service (average allowed $67.82).
Does Medicare cover J9308?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9308 can be billed per day?
280 on outpatient hospital claims; 280 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
- J9312 — Injection, rituximab, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9308
- Watch J9308 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9308
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.